- Tobacco Use in Bipolar Disorder
-
Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, Ellegaard , Berk L, Dean OM
- KMID: 2171060
- Clin Psychopharmacol Neurosci.
- 2015 Apr;13(1):1-11.
- doi: 10.9758/cpn.2015.13.1.1
Tobacco use in mental health in general and bipolar disorder in particular remains disproportionally common, despite declining smoking rates in the community. Furthermore, interactions between tobacco use and mental health... -
- CITED
-
- Close
- SHARE
-
- Close
- Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression
-
Russell SE, Wrobel AL, Dean OM, Berk M, Dodd S, Ng CH, Malhi GS, Cotton SM, Sarris J, Turner A
- KMID: 2530465
- Clin Psychopharmacol Neurosci.
- 2022 May;20(2):300-310.
- doi: 10.9758/cpn.2022.20.2.300
Objective: There is often a shortfall in recovery following treatment for an episode of bipolar disorder (BD). Exploration of participant’s experience provides vital information to enhance statistical outcomes for novel... -
- CITED
-
- Close
- SHARE
-
- Close
- The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial
-
Russell SE, Skvarc DR, Mohebbi M, Camfield D, Byrne LK, Turner A, Ashton MM, Berk M, Dodd S, Malhi GS, Cotton SM, Bush AI, Dean OM
- KMID: 2542940
- Clin Psychopharmacol Neurosci.
- 2023 May;21(2):320-331.
- doi: 10.9758/cpn.2023.21.2.320
Objective: N -acetylcysteine (NAC) is a novel therapeutic agent with multiple mechanisms of action in the central nervous system and a favourable side effect profile. Clinical evidence indicates that adjunctive... -
- CITED
-
- Close
- SHARE
-
- Close
- Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial
-
Dean OM, Maes M, Ashton M, Berk L, Kanchanatawan B, Sughondhabirom A, Tangwongchai S, Ng C, Dowling N, Malhi GS, Berk M
- KMID: 2279927
- Clin Psychopharmacol Neurosci.
- 2014 Dec;12(3):180-188.
- doi: 10.9758/cpn.2014.12.3.180
While current pharmacotherapies are efficacious, there remain a clear shortfall between symptom remission and functional recovery. With the explosion in our understanding of the biology of these disorders, the time... -
- CITED
-
- Close
- SHARE
-
- Close
- Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia
-
Turner A, McGrath JJ, Dean OM, Dodd S, Baker A, Cotton SM, Scott JG, Kavanagh B, Ashton MM, Walker AJ, Brown E, Berk M
- KMID: 2456733
- Clin Psychopharmacol Neurosci.
- 2019 Mar;17(2):297-307.
- doi: 10.9758/cpn.2019.17.2.297
OBJECTIVE: Garcinia mangostana Linn., commonly known as mangosteen, is a tropical fruit with a thick pericarp rind containing bioactive compounds that may be beneficial as an adjunctive treatment for schizophrenia.... -
- CITED
-
- Close
- SHARE
-
- Close
